The O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation is associated with a higher degree of survival in high-grade glioma, partly due to better treatment response to alkylating agents [9,26,27]. The gene discussed is MGMT; the disease is central nervous system cancer.